Recruiting
Phase 1

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Sponsor:

UCLA

Code:

NCT05979389

Conditions

NAFLD

PCOS

Eligibility Criteria

Sex: Female

Age: 18 - 40

Healthy Volunteers: Not accepted

Interventions

Bicalutamide 50 mg

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information